Literature DB >> 1334259

The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18.

M Remm1, R Brain, J R Jenkins.   

Abstract

Human papillomaviruses (HPV-s) have been shown to possess transforming and immortalizing activity for many different, mainly keratinocyte cell lines and they have been detected in 90% of anogenital cancer tissues, which suggests a causative role in the induction of anogenital and other tumours. We have exploited a quantitative assay to identify and characterize the origin of replication of the human papillomavirus type 18 (HPV-18), one of the most prevalent types in the high-risk HPV group. Replication of HPV origin fragments was studied transiently by cotransfection with a protein expression vector providing replication proteins E1 and E2. We have localized the HPV-18 origin to nucleotides 7767-119. This region contains three E2 binding sites and an essential A/T rich DNA region (nucleotides 9-35) that is partly homologous to the E1 binding site found in bovine papillomavirus type 1 (BPV-1) genome. At least one of the three E2 binding sites was absolutely required for origin function; addition of other E2 sites had cooperative stimulating effect. This is the first quantitative analysis of the E2 binding sites for papillomavirus replication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334259      PMCID: PMC334468          DOI: 10.1093/nar/20.22.6015

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

Review 1.  Transcriptional enhancers can act in trans.

Authors:  H P Müller; W Schaffner
Journal:  Trends Genet       Date:  1990-09       Impact factor: 11.639

2.  Regulation of DNA replication in vitro by the transcriptional activation domain of GAL4-VP16.

Authors:  L Z Cheng; J L Workman; R E Kingston; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

3.  Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region.

Authors:  B A Spalholz; P F Lambert; C L Yee; P M Howley
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

4.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

5.  Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay.

Authors:  M Sawadogo; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products.

Authors:  S T Cole; O Danos
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

7.  Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functions.

Authors:  M S Rabson; C Yee; Y C Yang; P M Howley
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

8.  Bidirectional promoter elements of simian virus 40 are required for efficient replication of the viral DNA.

Authors:  G Z Hertz; J E Mertz
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

9.  Isolation of mutants of an animal virus in bacteria.

Authors:  K W Peden; J M Pipas; S Pearson-White; D Nathans
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

10.  An initiation site of DNA replication with transcriptional enhancer activity present upstream of the c-myc gene.

Authors:  S M Iguchi-Ariga; T Okazaki; T Itani; M Ogata; Y Sato; H Ariga
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  39 in total

Review 1.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

2.  mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Authors:  Wentao Deng; Ge Jin; Biing-Yuan Lin; Brian A Van Tine; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

3.  p53 protein is a suppressor of papillomavirus DNA amplificational replication.

Authors:  D Lepik; I Ilves; A Kristjuhan; T Maimets; M Ustav
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

4.  Transcriptional and replicational activation functions in the bovine papillomavirus type 1 E2 protein are encoded by different structural determinants.

Authors:  A Abroi; R Kurg; M Ustav
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting.

Authors:  P H Bednarek; B J Lee; S Gandhi; E Lee; B Phillips
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Transcription factor YY1 represses cell-free replication from human papillomavirus origins.

Authors:  K Y Lee; T R Broker; L T Chow
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7.  E1 protein of human papillomavirus is a DNA helicase/ATPase.

Authors:  F J Hughes; M A Romanos
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

8.  Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements.

Authors:  C M Sanders; N J Maitland
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

Review 9.  A possible role for human papillomaviruses in head and neck cancer.

Authors:  B M Steinberg; T P DiLorenzo
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication.

Authors:  C D Newhouse; S J Silverstein
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.